For the past FY, Bastide has reported historical EBITDA and an above-guidance recurring EBIT margin, but the bottom line has been weakened by considerable non-recurring items, net financial expenses and net loss from discontinued operations. While the underlying EBIT guidance remains in line with our expectations, the non-recurring and net financial costs look unlikely to see a meaningful improvement shortly. We will cut our P&L estimates and our target price.
